Minimal invasive ablation techniques in small renal tumours treatment

Česká verzia

Authors: A. Čermák; D. Pacík
Published in the journal: Urol List 2012; 10(3): 16-23

Summary

The improvement in imaging methods has led to an increase in renal cancer incidence during a few last years. Most (approximately 70%) tumours localized in renal parenchym are stage T1a tumours and thus considered as small tumours (mean < 4 cm). These tumours are usually found incidentally during tests for other indication. Virtually 100% of patients are asymptomatic (considering renal cancer). Most tumours are diagnosed in lower stage – T1 without metastatic expansion or lymphatic invasion. Surgical treatment is currently recommended as the standard treatment of small renal masses (SRM). Where technically feasible nephron-sparing resection (partial nephrectomy) is also recommended. Laparoscopic resection represents an alternative to open surgery, but should only be reserved for experienced surgeons. Alternative, minimal invasive methods and conservative treatment can be indicated in selected patients, usually patients with comorbidities in whom surgical treatment would pose significant threat, or patients with short expected survival. The aim of alternative ablation techniques in patients with SRM is to decrease intraoperative morbidity. Percutaneous biopsy is performed to obtain material for histological examination and to select the most adequate treatment modality. Active surveillance should be reserved for patients with significant comorbidities and short expected survival.

Key words:
renal cancer, small renal masses, thermal ablation, cryoablation, interstitial photon radiation ablation therapy, laser ablation, irreversible electrovaporation, microwave therapy

Zdroje

1. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174(2): 323–331.

2. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008; 113(10): 2671–2680.

3. Long L, Park S. Differences in patterns of care: reablation and nephrectomy rates after needle ablative therapy for renal masses stratified by medical specialty. J Endourol 2009; 23(3): 421–426.

4. Zagoria RJ, Traver MA, Werle DM et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189(2): 429–436.

5. Varkarakis IM, Allaf ME, Inagaki T et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol 2005; 174(2): 456–460.

6. Hegarty NJ, Gill IS, Desai MM et al. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006; 68 (1 Suppl): 7–13.

7. Ferakis N, Bouropoulos C, Granitsas T et al. Longterm results after computed-tomography guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 2010; 24(12): 1909–1913.

8. Tracy CR, Raman JD, Donnally C et al. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116(13): 3135–3142.

9. Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. Eur Urol 2007; 51(2): 348–357.

10. Johnson DB, Solomon SB, Su LM et al. Defining the complications of cryoablation and radiofrequency ablation of small renal tumors: a multi-institutional review. J Urol 2004; 172(3): 874–877.

11. Gill IS, Remer EM, Hasan WA et al. Renal cryoablation: outcome at 3 years. J Urol 2005; 173(6): 1903–1907.

12. Weight CJ, Kaouk JH, Hegarty NJ et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179(4): 1277–1281.

13. Rendon RA, Kachura JR, Sweet JM et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 2002; 167(4): 1587–1592.

14. Matlaga BR, Zagoria RJ, Woodruff RD et al. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 2002; 168(6): 2401–2405.

15. Klingler HC, Marberger M, Mauermann J et al. ‘Skipping’ is still a problem with radiofrequency ablation of small renal tumours. BJU Int 2007; 99(5): 998–1001.

16. Hora M, Hes O, Klečka J. Miniinvazivní ledvinu šetřící ablační metodiky v léčbě nádorů ledvin. Urol List 2003; 1: 26–29.

17. Michaels MJ, Rhee HK, Mourtzinos AP et al. Incomplete renal tumor destruction using radio frequency intersti-tial ablation. J Urol 2002; 168(6): 2406–2410.

18. Rendon RA, Kachura JR, Sweet JM et al. The uncertainty of radio frequency treatment of renal cell carcinoma: Findings at immediate and delayed nephrectomy. J Urol 2002; 167(4): 1587–1592.

19. Walther MM, Shawker TH, Ligutti SK et al. A phase 2 study of radio frequency interstitial tissue ablativ of localized renal tumors. J Urol 2000; 163(5): 1424–1427.

20. Volpe A, Cadeddu JA, Cestari A et al. Contemporary management of small renal masses, European Urology 2011; 60(3): 501–515.

21. Klatte T, Patard JJ, de Martino M et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 2008; 179(5): 1719–1726.

22. Barocas DA, Rohan SM, Kao J et al. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J Urol 2006; 176(5): 1957–1962.

23. O’Malley RL, Godoy G, Kanofsky JA et al. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol 2009; 181(5): 2009–2017.

24. Kagebayashi Y, Hirao Y, Samma S et al. In situ non-ischemic enucleation of multiocular cystic renal cell carcinoma using a microwave coagulator. Int J Urol 1995; 2(5): 339–343.

25. Kigure T, Harada T, Yuri Y et al. Laparoscopic microwave thermotherapy on small renal tumors: experimental studies using implanted X- 2 tumors in rabbits. Eur Urol 1996; 30(3): 377–382.

26. Murphy DP, Gill IS. Energy-based renal tumor ablation: a review. Sem Urol Oncol 2001; 19(2): 133–140.

27. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (2 Suppl 1): 40–49.

28. Woolley ML, Schulsinger DA, Durand DB et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol 2002; 16(7): 519–522.

29. Tsivian M, Chen VH, Kim CY et al. Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol 2010; 58(1): 142–148.

30. Bandi G, Hedican S, Moon T et al. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol 2008; 22(5): 963–967.

31. Mues AC, Okhunov Z, Haramis G et al. Comparison of percutaneous and laparoscopic renal cryoablation for small (< 3,0 cm) renal masses. J Endourol 2010; 24(7): 1097–1100.

32. Beemster P, Phoa S,Wijkstra H et al. Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU Int 2008; 101(10): 1237–1242.

33. Bolte SL, Ankem MK, Moon TD et al. Magnetic resonance paging findings after laparoscopic renal cryoablation. Urology 2006; 67(3): 485–489.

34. Kolombo I. NanoKnife^{® (USA): chirurgie na subcelulární úrovni. Technický týdeník č. 24/2011.}

35. Pech M, Janitzky A, Wendler JJ et al. “Irreversible electroporation of Renal cell carcinoma: First in Man Human Phase 1 Clinical Study”, Cardiovasc Intervent Radiol 2011; 34(1): 132–138.

36. Tracy CR, Kabbani W, Cadeddu JA. Irreversible electroporation (IRE): a novel method for renal tissue Iablation BJU Int 2011; 107(12): 1982–1987.

37. Gronka L, Poršová M, Kolombo I et al. Karcinom ledviny – současné trendy. Urol pro praxi: 9(3): 120–127.

38. Poppel H, Becker F,Cadeddu JA et al. Treatment of Localised Renal Cell Carcinoma. Eur Urol 2011; 60(4): 662–672.